> 13- Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model.Beaurain M, Talmont F, Pierre D, Péran P, Boucher S, Hitzel A, Rols MP, Cuvillier O, Payoux P, Salabert AS.
Mol Imaging Biol. 2023 Mar 21. doi: 10.1007/s11307-023-01811-y. > 84- Reduced Regional Cerebral Blood Flow Measured by 99mTc-Hexamethyl Propylene Amine Oxime Single-Photon Emission Computed Tomography in Microgravity Simulated by 5-Day Dry Immersion.Guillon L, Kermorgant M, Charvolin T, Bonneville F, Bareille MP, Cassol E, Beck A, Beaurain M, Péran P, Lotterie JA, Traon AP, Payoux P.
Front Physiol. 2021 Nov 22;12:789298. doi: 10.3389/fphys.2021.789298. > 60- Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience.Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P.
Voir la publication
Front Med (Lausanne). 2019 Nov 27;6:268. doi: 10.3389/fmed.2019.00268. eCollection 2019. Review. > 72- Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats.Salabert AS, Mora-Ramirez E, Beaurain M, Alonso M, Fontan C, Tahar HB, Boizeau ML, Tafani M, Bardiès M, Payoux P.
Nucl Med Biol. 2017 Dec 21;59:1-8. doi:10.1016/j.nucmedbio.2017.12.003. > 48- Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.Salabert AS, Vaysse L, Beaurain M, Alonso M, Arribarat G, Lotterie JA, Loubinoux I, Tafani M, Payoux P.
PLoS One. 2017 Sep 19;12(9):e0184630. doi: 10.1371/journal.pone.0184630. eCollection 2017.